Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:853-862

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touyz, R. M.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touyz, R. M.
Right arrow Articles by Schiffrin, E. L.

Hypertension, Vol 22, 853-862, Copyright © 1993 by American Heart Association


ARTICLES

Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension

RM Touyz and EL Schiffrin
Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada.

The aims of this study were to determine the relations between platelet free calcium concentrations ([Ca2+]i), intracellular pH (pHi), and aggregation and to assess the effects of angiotensin II (Ang II) and endothelin-1 on these platelet parameters in normotensive subjects and hypertensive patients. Seventeen normotensive subjects, 25 untreated hypertensive patients, and 34 treated hypertensive patients were studied. Platelet cytosolic free [Ca2+]i and pHi were measured spectrofluorometrically using specific fluorescent probes (fura 2-AM and BCECF-AM, respectively) in unstimulated and Ang II- and endothelin- 1-stimulated platelets. Aggregation was measured by a turbidometric technique. Basal [Ca2+]i (141 +/- 11 nmol/L) and pH (7.16 +/- 0.01) were higher (P < .05) in the untreated hypertensive group compared with the normotensive (118 +/- 9 nmol/L, 7.11 +/- 0.01, respectively) and treated hypertensive (121 +/- 11 nmol/L, 7.12 +/- 0.01, respectively) groups. In the combined normotensive and hypertensive groups, there were significant correlations between [Ca2+]i and mean arterial pressure (r = .75, P < .01), pHi and mean arterial pressure (r = .72, P < .01), [Ca2+]i and pHi (r = .71, P < .01), [Ca2+]i and aggregation (r = .69, P < .02), and pHi and aggregation (r = .56, P < .05). Ang II stimulation significantly increased [Ca2+]i and pHi in the untreated hypertensive and normotensive groups. The net change in [Ca2+]i induced by Ang II was significantly higher (P < .05) in the untreated hypertensive group compared with the other groups (67 +/- 6 nmol/L for the untreated hypertensive group versus 54 +/- 5 and 29 +/- 8 nmol/L for the normotensive and treated hypertensive groups, respectively). In the presence of Ang II, thrombin-induced aggregatory responses were increased in all three groups, but the maximal response was significantly higher in the untreated hypertensive group compared with the other groups (P < .05). Endothelin-1 increased pHi through endothelin A-receptors (effect blocked by the specific antagonist BQ- 123) but had no significant effect on [Ca2+]i or aggregation. However, endothelin-1 blunted thrombin-induced platelet aggregation in normotensive subjects but not in hypertensive patients. In conclusion, increased Ang II-stimulated [Ca2+]i and pHi in platelets of essential hypertensive patients may be associated with increased aggregatory responses. The stimulatory effect of endothelin-1 on pHi but not on [Ca2+]i or aggregation suggests that in platelets endothelin-induced signaling pathways other than phospholipase C may be involved.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
Min Pan, M.-H. Jiang, M.-F. Wei, Z.-H. Liu, W.-P. Jiang, H.-H. Geng, Z.-C. Cui, D.-L. Zhang, and J.-H. Zhu
Association of Angiotensin-Converting Enzyme Gene 2350G>A Polymorphism With Myocardial Infarction in a Chinese Population
Clinical and Applied Thrombosis/Hemostasis, August 1, 2009; 15(4): 435 - 442.
[Abstract] [PDF]


Home page
Eur Heart JHome page
I. Chung and G. Y.H. Lip
Platelets and heart failure
Eur. Heart J., November 2, 2006; 27(22): 2623 - 2631.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. K. Naber, J. Husing, U. Wolfhard, R. Erbel, and W. Siffert
Interaction of the ACE D Allele and the GNB3 825T Allele in Myocardial Infarction
Hypertension, December 1, 2000; 36(6): 986 - 989.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. P. Blaustein and W. J. Lederer
Sodium/Calcium Exchange: Its Physiological Implications
Physiol Rev, July 1, 1999; 79(3): 763 - 854.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Horiguchi, M. Kimura, J. Skurnick, and A. Aviv
Parameters of Lymphocyte Na+-Ca2+ Regulation and Blood Pressure : The Gender Effect
Hypertension, November 1, 1998; 32(5): 869 - 874.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Fujise, L. Stacy, P. Beck, E. T.H. Yeh, A. Chuang, T. A. Brock, and J. T. Willerson
Differential Effects of Endothelin Receptor Activation on Cyclic Flow Variations in Rat Mesenteric Arteries
Circulation, November 18, 1997; 96(10): 3641 - 3646.
[Abstract] [Full Text]


Home page
CirculationHome page
F. Diet, R. E. Pratt, G. J. Berry, N. Momose, G. H. Gibbons, and V. J. Dzau
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Circulation, December 1, 1996; 94(11): 2756 - 2767.
[Abstract] [Full Text]


Home page
HypertensionHome page
J. Marcil, E. L. Schiffrin, and M. B. Anand-Srivastava
Aberrant Adenylyl Cyclase/cAMP Signal Transduction and G Protein Levels in Platelets From Hypertensive Patients Improve With Antihypertensive Drug Therapy
Hypertension, July 1, 1996; 28(1): 83 - 90.
[Abstract] [Full Text]


Home page
HypertensionHome page
W. Siffert and R. Dusing
Sodium-Proton Exchange and Primary Hypertension : An Update
Hypertension, October 1, 1995; 26(4): 649 - 655.
[Abstract] [Full Text]